BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33636699)

  • 1. Resection of primary central nervous system lymphoma: impact of patient selection on overall survival.
    Schellekes N; Barbotti A; Abramov Y; Sitt R; Di Meco F; Ram Z; Grossman R
    J Neurosurg; 2021 Feb; 135(4):1016-1025. PubMed ID: 33636699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Outcome and Overall Survival in Patients with Primary or Secondary CNS Lymphoma after Surgical Resection vs. Biopsy.
    Staub-Bartelt F; Rittenauer J; Sabel M; Rapp M
    Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of surgical resection in primary central nervous system lymphoma: a single-center retrospective analysis of 70 patients.
    Wu S; Wang J; Liu W; Hu F; Zhao K; Jiang W; Lei T; Shu K
    BMC Neurol; 2021 May; 21(1):190. PubMed ID: 33975554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
    Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
    [No Abstract]   [Full Text] [Related]  

  • 5. Whether surgical resection or biopsy makes difference in single lesion primary central nervous system lymphoma: a single center retrospective cohort study.
    Cheng X; Chen H; Sun C; Zhang B; Zhang J; Wang Y
    BMC Neurol; 2022 Nov; 22(1):411. PubMed ID: 36333683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical resection versus biopsy in the treatment of primary central nervous system lymphoma: a systematic review and meta-analysis.
    Chojak R; Koźba-Gosztyła M; Polańska K; Rojek M; Chojko A; Bogacz R; Skorupa N; Więcław J; Czapiga B
    J Neurooncol; 2022 Dec; 160(3):753-761. PubMed ID: 36449256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resection or Biopsy: The Efficacy of Different Surgical Approaches for Primary Central Nervous System Lymphoma.
    Zhang Y; Wang Z; Wang D; Yu B; Wen J; He S; Zeng W; Wang C
    Turk Neurosurg; 2024; 34(3):401-406. PubMed ID: 38650554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resection versus biopsy for management of primary central nervous system lymphoma: a meta-analysis.
    Stifano V; Della Pepa GM; Offi M; Montano N; Carcagnì A; Pallini R; Lauretti L; Olivi A; D'Alessandris QG
    Neurosurg Rev; 2023 Jan; 46(1):37. PubMed ID: 36645525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics, Surgical Outcomes, and Prognostic Factors of Intracranial Primary Central Nervous System Lymphoma.
    Ouyang T; Wang L; Zhang N; Zhang Z; Xiong Y; Li M; Hong T
    World Neurosurg; 2020 Jul; 139():e508-e516. PubMed ID: 32311566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Craniotomy and Survival for Primary Central Nervous System Lymphoma.
    Rae AI; Mehta A; Cloney M; Kinslow CJ; Wang TJC; Bhagat G; Canoll PD; Zanazzi GJ; Sisti MB; Sheth SA; Connolly ES; McKhann GM; Bruce JN; Iwamoto FM; Sonabend AM
    Neurosurgery; 2019 Apr; 84(4):935-944. PubMed ID: 29660011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety of resection for primary central nervous system lymphoma: a single institution retrospective analysis.
    Cloney MB; Sonabend AM; Yun J; Yang J; Iwamoto F; Singh S; Bhagat G; Canoll P; Zanazzi G; Bruce JN; Sisti M; Sheth S; Connolly ES; McKhann G
    J Neurooncol; 2017 Mar; 132(1):189-197. PubMed ID: 28116650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical Resection for Primary Central Nervous System Lymphoma: A Systematic Review.
    Labak CM; Holdhoff M; Bettegowda C; Gallia GL; Lim M; Weingart JD; Mukherjee D
    World Neurosurg; 2019 Jun; 126():e1436-e1448. PubMed ID: 30904794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of surgery in intracranial PCNSL.
    Jahr G; Da Broi M; Holte H; Beiske K; Meling TR
    Neurosurg Rev; 2018 Oct; 41(4):1037-1044. PubMed ID: 29383600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of comorbidity indices and histochemical markers in surgically resected and non-resected primary central nervous system lymphoma.
    Wong CE; Liao WA; Chang Y; Lee PH; Huang CC; Chang KC; Lee JS
    Clin Exp Med; 2023 Nov; 23(7):3799-3807. PubMed ID: 37491648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL).
    Bergner N; Monsef I; Illerhaus G; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009355. PubMed ID: 23152274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemorrhagic Attitude in Frameless and Frame-Based Stereotactic Biopsy for Deep-Seated Primary Central Nervous System Lymphomas in Immunocompetent Patients: A Multicentric Analysis of the Last Twenty Years.
    Callovini GM; Sherkat S; Sperduti I; Crispo F; Raus L; Gazzeri R; Telera S
    World Neurosurg; 2021 May; 149():e1017-e1025. PubMed ID: 33476784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery plus adjuvant radiotherapy for primary central nervous system lymphoma.
    Kinslow CJ; Rae AI; Neugut AI; Adams CM; Cheng SK; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Iwamoto FM; Sonabend AM; Wang TJC
    Br J Neurosurg; 2020 Dec; 34(6):690-696. PubMed ID: 31931632
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic impact of peripheral natural killer cells in primary central nervous system lymphoma.
    Lin Z; Ma J; Ma Y; Li Q; Kang H; Zhang M; Chen B; Xia R
    Front Immunol; 2023; 14():1191033. PubMed ID: 37426647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.